<div class="row">
    <div class=" medium-12 row collapse">
        <h1>Resources</h1>
    </div>
</div>
<section class="group-section no-box-shadow">
    <div class="accordion">
        <div class="strengths">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.strengths')">
                <span class="text">Strengths and Limitations of Common EHCO Parameters</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="page-wrapper">
                        <table class="table banded small-12 medium-12">
                            <thead>
                                <tr>
                                    <th>Parameter</th>
                                    <th>Strengths</th>
                                    <th>Weaknesses</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Valve Morphology</td>
                                    <td>
                                        Flail leaflets or ruptured
                                        papillary muscles are specific
                                        for severe MR
                                    </td>
                                    <td>Other findings are non-specific</td>
                                </tr>
                                <tr>
                                    <td>Regurgitant Color Flow</td>
                                    <td>
                                        Easy to use, evaluates spatial
                                        orientation of MR jet,
                                        differentiates mild versus
                                        severe
                                    </td>
                                    <td>
                                        Subject to technical and
                                        hemodynamic variation; can be
                                        underestimated with wallimpinging
                                        jets; image qualitydependent
                                    </td>
                                </tr>
                                <tr>
                                    <td>Vena Contracta Width</td>
                                    <td>
                                        Quick and easy to use;
                                        independent of hemodynamic
                                        and instrumentation factors;
                                        applies to eccentric jets; can
                                        differentiate mild versus
                                        severe MR
                                    </td>
                                    <td>
                                        Not applicable to multiple jets;
                                        intermediate values require
                                        confirmation; small
                                        measurement errors can lead to
                                        big changes; 2D measure of a
                                        3D structure; limited lateral
                                        resolution
                                    </td>
                                </tr>
                                <tr>
                                    <td>
                                        Proximal Isovelocity Surface
                                        Area (PISA)
                                    </td>
                                    <td>
                                        Can be applied to eccentric
                                        jets (when angle corrected);
                                        not affected by etiology of
                                        MR; quantitative: provides
                                        both lesion severity (EROA)
                                        and volume data (R Vol); flow
                                        convergence at Nyquist limit
                                        of 50�60 cm/s alerts reader to
                                        significant MR
                                    </td>
                                    <td>
                                        Not valid with multiple jets;
                                        provides peak flow and
                                        maximal EROA; inter-observer
                                        variability; errors in radius
                                        measurement are squared;
                                        multiple potential sources of
                                        measurement error
                                    </td>
                                </tr>
                                <tr>
                                    <td>Flow Quantitation�PW</td>
                                    <td>
                                        Quantitative; valid in multiple
                                        jets and eccentric jets;
                                        provides both lesion severity
                                        (EROA, RF) and volume data
                                        (RVol)
                                    </td>
                                    <td>
                                        Time consuming; measurement
                                        of flow at MV annulus less
                                        reliable with calcified MV
                                        and/or annulus; not valid with
                                        concomitant significant AR
                                        unless pulmonic site is used;requires measurement at
                                        multiple sites, which
                                        introduces errors
                                    </td>
                                </tr>
                                <tr>
                                    <td>Jet Profile�CW</td>
                                    <td>
                                        Simple, readily available<br>
                                        Easy assessment of MR timing
                                    </td>
                                    <td>
                                        Qualitative; complementary
                                        data; complete signal difficult
                                        to obtain in eccentric jet; gain
                                        dependent
                                    </td>
                                </tr>
                                <tr>
                                    <td>Peak Mitral E Velocity</td>
                                    <td>
                                        Simple, readily available, Awave
                                        dominance excludes
                                        severe MR
                                    </td>
                                    <td>
                                        Influenced by LA
                                        pressure/compliance, LV
                                        relaxation, MV area, and AF;
                                        complementary data only, does
                                        not quantify MR severity
                                    </td>
                                </tr>
                                <tr>
                                    <td>Pulmonary Vein Flow</td>
                                    <td>
                                        Simple; systolic flow reversal
                                        is specific for severe MR
                                    </td>
                                    <td>
                                        Influenced by LA pressure,
                                        AF; not accurate if MR jet
                                        directed into the sampled vein;
                                        absence does not rule out
                                        severe MR
                                    </td>

                                </tr>
                                <tr>
                                    <td>LA and LV Size</td>
                                    <td>
                                        Enlargement sensitive for
                                        chronic severe MR, important
                                        for outcomes; normal size
                                        virtually excludes severe
                                        chronic MR
                                    </td>
                                    <td>
                                        Enlargement seen in other
                                        conditions (non-specific); may
                                        be normal in acute severe MR
                                    </td>
                                </tr>

                            </tbody>
                        </table>
                        <span class="bold">
                            Abbreviations: AF = atrial fibrillation; AR = aortic regurgitation; CW = continuous w ave; EROA = effective<br>
                            regurgitant orifice area; LA = left atrium; LV = left ventricle; MR = mitral regurgitation; MV = mitral valve; RF =regurgitant fraction; RVol = regurgitant volume
                        </span>
                    </div>
                </div>
            </div>
        </div>
        <div class="pathoanatomically">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.pathoanatomically')">
                <span class="text">Pathoanatomically Directed Surgical Techniques for MR</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <table class="table">
                        <colgroup>
                            <col width="30">
                            <col width="180">
                        </colgroup>
                        <tbody>
                            <tr class="seperator">
                                <td colspan="2">Primary Mitral Regurgitation</td>
                            </tr>
                            <tr>
                                <td>1.</td>
                                <td>
                                    Non-resection techniques using either polytetrafluorethylene (PTFE) neochord reconstruction or ipsilateral chordal transfer from secondary to primary position, with annuloplasty ring
                                    <ul>
                                        <li>May be used for focal leaflet flail or bileaflet prolapse</li>
                                        <li>May be used for forme fruste* diffuse myxomatous disease of the posterior leaflet</li>
                                        <li>May be used for isolated anterior leaflet prolapse</li>
                                    </ul>
                                </td>
                            </tr>
                            <tr>
                                <td>2.</td>
                                <td>
                                    Focal triangular resection with annuloplasty ring
                                    <ul>
                                        <li>May be used for focal leaflet flail of the posterior or commissural leaflet</li>
                                        <li>Rarely may be used for focal anterior leaflet defects</li>
                                    </ul>
                                </td>
                            </tr>
                            <tr>
                                <td>3.</td>
                                <td>
                                    Sliding leaflet valvuloplasty with annuloplasty ring
                                    <ul>
                                        <li>May be used for forme fruste* diffuse posterior leaflet myxomatous disease</li>
                                        <li>May be used in the setting of bileaflet prolapse with excess posterior leaflet</li>
                                        <li>
                                            May be used in any of the above with significant echocardiographic predictors of
                                            systolic anterior motion of the anterior mitral valve leaflet
                                        </li>
                                    </ul>
                                </td>
                            </tr>
                            <tr class="seperator bold"><td colspan="2" class="bold">Secondary Mitral Regurgitation</td></tr>
                            <tr>
                                <td>1.</td>
                                <td>
                                    Restrictive remodeling rigid annuloplasty ring
                                    <ul>
                                        <li>May be used as primary modality for annular dilatation mechanism</li>
                                        <li>May be used in conjunction with secondary or tertiary chordal cutting</li>
                                        <li>May be used with other adjunctive procedures (i.e., papillary muscle sling)</li>
                                        <li>
                                            Should be avoided as sole therapy in setting of Carpentier Type IIIB mechanism with
                                            left ventricular inferobasal aneurysm
                                        </li>
                                    </ul>
                                </td>
                            </tr>
                            <tr>
                                <td>2.</td>
                                <td>
                                    Chord-sparing mitral valve replacement
                                    <ul>
                                        <li>
                                            May be used as primary modality for annular dilatation with severe leaflet tethering
                                            (i.e., &gt; 10 mm tenting height) or presence of inferobasal aneurysm
                                        </li>
                                    </ul>
                                </td>
                            </tr>

                        </tbody>
                    </table>
                    <span>* See text. Forme fruste refers to a pathoanatomic form of primary MR intermediate between fibroelastic deficiency and Barlow�s disease.</span>
                </div>
            </div>
        </div>
        <div class="feasibility">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.feasibility')">
                <span class="text">Feasibility of Surgical Mitral Valve Repair</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="page-wrapper">
                        <table class="table banded">
                            <thead>
                                <tr>
                                    <th></th>
                                    <th>Ideal Pathoanatomy</th>
                                    <th>Challenging Pathoanatomy</th>
                                    <th>Relative Pathoanatomic Contraindications</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Primary Lesion Location</td>
                                    <td>Posterior Leaflet only</td>
                                    <td>Anterior Leaflet or Bi-leaflet</td>
                                    <td>None</td>
                                </tr>
                                <tr>
                                    <td>Leaflet calcification</td>
                                    <td>None</td>
                                    <td>Mild</td>
                                    <td>Moderate to severe</td>
                                </tr>
                                <tr>
                                    <td>Annular calcification</td>
                                    <td>None</td>
                                    <td>
                                        Mild to moderate with
                                        minimal leaflet encroachment
                                    </td>
                                    <td>
                                        Severe or with significant
                                        leaflet encroachment
                                    </td>
                                </tr>
                                <tr>
                                    <td>Subvalvular Apparatus</td>
                                    <td>Thin, normal</td>
                                    <td>
                                        Mild diffuse thickening or
                                        moderate focal thickening
                                    </td>
                                    <td>
                                        Severe and diffuse thickening
                                        with leaflet retraction
                                    </td>
                                </tr>
                                <tr>
                                    <td>Mechanism of MR</td>
                                    <td>
                                        Type II fibroelastic
                                        deficiency or focal
                                        myxomatous prolapse
                                        or flail
                                    </td>
                                    <td>
                                        Type II forme fruste or
                                        bileaflet myxomatous
                                        (Barlow�s) disease; Type I
                                        healed or active endocarditis;
                                        Type III A/B with mild
                                        restriction or leaflet thickening
                                    </td>
                                    <td>
                                        Type IIIB with severe
                                        tethering and inferobasal
                                        aneurysm; Type IIIA with
                                        severe bileaflet calcification,
                                        Type I active infection with
                                        severe leaflet or annular
                                        tissue destruction
                                    </td>
                                </tr>
                                <tr>
                                    <td>Unique Anatomic Complexities</td>
                                    <td>None</td>
                                    <td>
                                        Redo cardiac operation or
                                        mitral re-repair; anatomic
                                        predictors of systolic anterior
                                        motion (i.e. septal
                                        hypertrophy); adult congenital
                                        anomalies; focal papillary
                                        muscle rupture
                                    </td>
                                    <td>
                                        Mitral valve reoperation with
                                        paucity of leaflet tissue;
                                        diffuse radiation
                                        valvulopathy; papillary
                                        muscle rupture with shock
                                    </td>
                                </tr>

                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
        <div class="eligibility">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.eligibility')">
                <span class="text">Eligibility for Transcatheter Mitral Valve Clip</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="column small-12">
                        <div class="page-wrapper">
                            <div class=" medium-12 row collapse">
                                <h4>Algorithm for Determining Eligibility for Transcatheter Edge-to-Edge Mitral Valve Clip</h4>
                            </div>
                            <div class="row group-section small-12 no-box-shadow">
                                <img class="highwire-fragment" alt="Figure&nbsp;12" src="assets/img/figure12.png" style="margin: 0 auto;display: block;">
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div class="feasibilityEdge">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.feasibilityEdge')">
                <span class="text">Feasibility of Transcatheter Edge-to-Edge Clip Repair</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="page-wrapper">
                        <table class="table banded">
                            <thead>
                                <tr>
                                    <th></th>
                                    <th>Ideal Echo Features</th>
                                    <th>Challenging Echo Features</th>
                                    <th>Relative Echo Contra-indications</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Location of Pathology</td>
                                    <td><ul><li>Segment 2</li></ul></td>
                                    <td><ul><li>Segments 1 or 3</li></ul></td>
                                    <td>
                                        <ul>
                                            <li>
                                                Body of leaflet (i.e. perforation
                                                or cleft/deep fold)
                                            </li>
                                        </ul>
                                    </td>
                                </tr>
                                <tr>
                                    <td>Calcification</td>
                                    <td><ul><li>None</li></ul></td>
                                    <td>
                                        <ul>
                                            <li>Mild, outside grasping zone</li>
                                            <li>Extensive annular calcification</li>
                                        </ul>
                                    </td>
                                    <td><ul><li>Severe calcification at site of grasping zone</li></ul></td>
                                </tr>
                                <tr>
                                    <td>Mitral Valve Area/Gradient</td>
                                    <td>
                                        <ul>
                                            <li>&gt;4 cm<sup>2</sup></li>
                                            <li>&le;4 mmHg</li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul>
                                            <li>
                                                &gt;3.5 cm<sup>2</sup> &lt;4 cm<sup>2</sup> with small BSA or very
                                                mobile leaflets
                                            </li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul>
                                            <li>&lt;4.0 cm<sup>2</sup></li>
                                            <li>&gt;5 mmHg</li>
                                        </ul>
                                        Especially if severe MAC
                                    </td>
                                </tr>
                                <tr>
                                    <td>Grasping zone Length </td>
                                    <td><ul><li>&gt;10 mm</li></ul> </td>
                                    <td>
                                        <ul><li>7-10 mm</li></ul>
                                    </td>
                                    <td>
                                        <ul><li>&lt;7 mm</li></ul>
                                    </td>
                                </tr>
                                <tr>
                                    <td>Functional MR</td>
                                    <td>
                                        <ul>
                                            <li>Normal thickness and mobility</li>
                                            <li>Coaptation depth &lt;11 mm</li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul>
                                            <li>Carpentier IIIB (restricted)</li>
                                            <li>Coaptation depth &gt;11 mm</li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul><li>Carpentier IIIA (rheumatic thickening and restriction)</li></ul>
                                    </td>
                                </tr>
                                <tr>
                                    <td>Degenerative MR </td>
                                    <td>
                                        <ul>
                                            <li>Flail width &lt;15 mm</li>
                                            <li>Flail gap &lt;10 mm</li>
                                            <li>Leaflet separation &lt; 2 mm</li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul>
                                            <li>
                                                Flail width &gt;15 mm with large valve area
                                                and option for &gt;1 MitraClip
                                            </li>
                                            <li>Flail gap &gt;10 mm</li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul>
                                            <li>
                                                Barlow's disease with significant
                                                regurgitation segments 1-3
                                            </li>
                                        </ul>
                                    </td>
                                </tr>
                                <tr>
                                    <td>Other Pathology</td>
                                    <td></td>
                                    <td>
                                        <ul>
                                            <li>Annuloplasty ring with adequate mitral valve area and leaflet length</li>
                                            <li>HOCM with Systolic anterior motion</li>
                                            <li>
                                                Extreme disease (Markedly dilated annulus or
                                                EROA &ge;70.8 mm<sup>2</sup>)
                                            </li>
                                        </ul>
                                    </td>
                                    <td>
                                        <ul><li>Endocarditis with vegetations</li></ul>
                                    </td>
                                </tr>

                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
        <div class="clinician">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.clinician')">
                <span class="text">Clinician Tools</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="column small-12">
                        <p>Click on each of the tools below to access on the web:</p>
                        <p><a target="_blank" class="link" href="https://www.acc.org/-/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Tools-and-Practice-Support/Quality-and-Clinical-Toolkits/Valvular-Heart-Disease/MR-Referral-Toolkit.pdf">Mitral Regurgitation Referral Toolkit</a></p>
                        <p><a target="_blank" class="link" href="https://www.acc.org/-/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Tools-and-Practice-Support/Quality-and-Clinical-Toolkits/Valvular-Heart-Disease/ECHO-checklist.pdf">Mitral Regurgitation ECHO Checklist</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/education-and-meetings/image-and-slide-gallery/media-detail?id=425ec50ce2244cc691a4434f858d0dd1">ACC Valvular Heart Disease Guideline Tool</a></p>
                        <p><a target="_blank" class="link" href="http://riskcalc.sts.org/stswebriskcalc/#/">STS Adult Cardiac Surgery Risk Calculator</a></p>
                    </div>
                </div>
            </div>
        </div>
        <div class="patient">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.patient')">
                <span class="text">Patient Tools and Resources</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="column small-12">
                        <p>Click on each of the tools below to access on the web: </p>
                        <p><a target="_blank" class="link" href="https://www.cardiosmart.org/Heart-Conditions/Mitral-Valve-Regurgitation">Mitral Regurgitation Condition Information Center</a></p>
                        <p><a target="_blank" class="link" href="https://www.cardiosmart.org/topics/mitral-regurgitation/overview">�Understanding MR� patient brochure</a></p>
                        <p><a target="_blank" class="link" href="https://www.cardiosmart.org/~/media/Documents/Worksheets/I-Have-MR-Now-What.ashx">�I Have MR, Now What� Patient Guide</a></p>
                        <p><a target="_blank" class="link" href="https://www.cardiosmart.org/~/media/Documents/Worksheets/My-MR-Tracker.ashx">�MR Tracker� patient worksheet</a></p>
                        <p><a target="_blank" class="link" href="https://www.cardiosmart.org/~/media/Documents/Worksheets/About-My-MR.ashx">�About My MR� clinician-patient worksheet</a></p>
                    </div>
                </div>
            </div>
        </div>
        <div class="other">
            <h4 class="toggle with-underline" onclick="panelVisibleToggle('.other')">
                <span class="text">Other Mobile Tools</span><i class="fa fa-holder right"></i>
            </h4>
            <div class="collapsable-panel" style="display: none;">
                <div class="row">
                    <div class="column small-12">
                        <p>Click below to download ACC�s other clinical mobile apps </p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/guideline-clinical-app">ACC Guideline Clinical App</a></p>
                        <p><a target="_blank" class="link" href="http://tools.acc.org/TAVRRisk/?_ga=2.149080948.394511975.1495745924-237461518.1450120708#!/content/evaluate/">TAVR In-hospital Mortality Risk Calculator</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/anticoag-evaluator">AnticoagEvaluator</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/bridgeanticoag-app">BridgeAnticoag</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/dapt-risk-calculator">DAPT Risk Calculator</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/icd-crt-appropriate-use-criteria-app">ICD/CRT Appropriate Use Criteria App</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/2013-prevention-guidelines-ascvd-risk-estimator">ASCVD Risk Estimator Plus</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/ldl-c-manager">LDL-C Manager</a></p>
                        <p><a target="_blank" class="link" href="http://www.acc.org/tools-and-practice-support/mobile-resources/features/CathPCI-Bleed-Risk-App">CathPCI Bleeding Risk Calculator</a></p>
                        <p><a target="_blank" class="link" href="https://itunes.apple.com/us/app/cardiosmart-explorer-for-members/id602929990?mt=8">CardioSmart Explorer</a></p>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>
<div class="row">
    <div class=" medium-12 row collapse">
        <h1>References</h1>
    </div>
</div>
<section class="group-section no-box-shadow">
    <p><a target="_blank" class="link" href="https://www.ncbi.nlm.nih.gov/pubmed/22032935">Carpentier Atrial View Image: Castillo JG, Sol�s J, Gonz�lez-Pinto �, Adams DH. Surgical Echocardiography of the Mitral Valve. Revista Espa�ola de Cardiolog�a (English Edition) 2011;64:1169-1181.</a></p>
    <p><a target="_blank" class="link" href="https://www.jacc.org/doi/10.1016/j.jacc.2017.09.019">O�Gara PT, Grayburn PA, Badhwar V, Afonso LC, Carroll JD, Elmariah S, Kithcart AP, Nishimura RA, Ryan T, Schwartz A, Stevenson LW. 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathway.</a></p>
    <p><a target="_blank" class="link" href="http://www.onlinejacc.org/content/early/2017/03/10/j.jacc.2017.03.011?_ga=2.184091814.1067745833.1495725865-237461518.1450120708">Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP,  Fleisher LA,  Jneid H, Mack MJ, McLeod CJ, O�Gara PT, Rigolin VH,  Sundt TM, Thompson A. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J AM Coll Cardiol 2017: DOI: 10.1016/j.jacc.2017.03.011</a></p>
    <p><a target="_blank" class="link" href="http://www.onlinejacc.org/content/63/22/e57">Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP,  Guyton RA, O�Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J AM Coll Cardiol 2014:63;57-185</a></p>
</section>